Slingshot members are tracking this corporate initiative:
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jul 26, 2016 Projected Implementation: Q3, 2016 Relevance Tracked Until: Q4, 2016
Don’t see a project related to the strategic initiative you care about?
Related Keywords Antigen-presentation Therapeutic, Jnj-64041757, Prostate Cancer, Opdivo, Non-small Cell Lung Cancer, Jnj-64041809, Listeria Monocytogenes, Adu-214, Adu-741, Pd-1 Immune Checkpoint Inhibitor, Nivolumab